TRASTUZUMAB-REZETECAN

Clinical trials for TRASTUZUMAB-REZETECAN explained in plain language.

Never miss a new study

Get alerted when new TRASTUZUMAB-REZETECAN trials appear

Sign up with your email to follow new studies for TRASTUZUMAB-REZETECAN, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New breast cancer drug under Real-World scrutiny in 300-Patient study

Disease control Recruiting now

This study is observing how well the drug trastuzumab-rezetecan works and how safe it is for people with HER2-positive or HER2-low breast cancer in real-world medical settings. It will follow 300 patients who are already scheduled to receive this treatment as part of their regula…

Matched conditions: TRASTUZUMAB-REZETECAN

Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University • Aim: Disease control

Last updated Apr 01, 2026 14:42 UTC

TRASTUZUMAB-REZETECAN

Get alerted when new TRASTUZUMAB-REZETECAN trials appear

New breast cancer drug under Real-World scrutiny in 300-Patient study